Lower Cholesterol Treatment Breakthrough
GORDON, Sydney, Australia, Aug. 30, 2018/Medianet International-AsiaNet/ -- The US offshoot of Australian biotech Noxopharm, Nyrada, believes it is within reach of achieving a major advance in the treatment of cardiovascular disease. It has made important progress with a drug candidate known as NYX-330 that Nyrada believe...
Read more https://view-release/?pr-id=74946